Parents…self-care matters, and it starts with your health

Learn how you can catch up on your health

Oct 14, 2022

Presented by HEPLISAV-B Hey parents, it's time to catch up on your health   Your child likely received their hepatitis B vaccine at birth, but if you were born before 1991, you may be living unprotected.   CATCH UP WITH HEPLISAV-B

Get caught up   The CDC now recommends all adults aged 19-59* get caught up.   FIND A PHARMACY

2 doses. 1 month. Done.   Only HEPLISAV-B can help you get caught up without having to flip through your calendar.

There is no cure for hepatitis B— prevention is essential   Hepatitis B is 100× more infectious than HIV ~296 million people are living with hepatitis B† New hepatitis B infections are highest among adults aged 30-59 years

Get ready to take care of yourself!     FIND A PHARMACY

*The CDC also recommends hepatitis B vaccination for adults aged ≥60 with risk factors. Adults aged ≥60 without risk factors may receive hepatitis B vaccination. †Estimate based on World Health Organization data from 2019. CDC, Centers for Disease Control and Prevention. INDICATION HEPLISAV-B is indicated for the prevention of infection caused by the hepatitis B virus in adults 18 years of age and older. IMPORTANT SAFETY INFORMATION If you have a history of severe allergic reaction after a previous dose of any hepatitis B vaccine, or to any ingredient of HEPLISAV-B, including yeast, do not take HEPLISAV-B. HEPLISAV-B must be given by a medical professional, who will monitor you afterwards to check for allergic reaction. If you are immunocompromised, or receiving immunosuppressant therapy, you may have less of an immune response to HEPLISAV-B. Some people have hepatitis B infection without being aware of it or showing any symptoms. If you already have hepatitis B present in your body, HEPLISAV-B may not prevent hepatitis B infection. The most common side effects reported by patients within 7 days of vaccination with HEPLISAV-B were pain at the site of injection (23%-39%), tiredness (11%-17%), and headache (8%-17%). Please see full Prescribing Information. © 2022 Dynavax Technologies Corporation. All rights reserved. US-22-00-00417

You're receiving this email because you signed up to receive communications from BDG Media. If you believe this has been sent to you in error, please safely unsubscribe. 315 Park Ave. South, New York, NY 10010 Copyright 2022 BDG Media, Inc. All rights reserved. View in browser